The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).

MLA

Remme, Willem J., et al. “The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN).” Cardiovascular Drugs and Therapy, vol. 18, no. 1, Jan. 2004, pp. 57–66. EBSCOhost, https://doi.org/10.1023/B:CARD.0000025756.32499.6f.

APA

Remme, W. J., Riegger, G., Hildebrandt, P., Komajda, M., Jaarsma, W., Bobbio, M., Soler-Soler, J., Scherhag, A., Lutiger, B., & Rydén, L. (2004). The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovascular Drugs and Therapy, 18(1), 57–66. https://doi.org/10.1023/B:CARD.0000025756.32499.6f

Chicago

Remme, Willem J, Guenter Riegger, Per Hildebrandt, Michel Komajda, Wybren Jaarsma, Marco Bobbio, Jordi Soler-Soler, Armin Scherhag, Beatrix Lutiger, and Lars Rydén. 2004. “The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN).” Cardiovascular Drugs and Therapy 18 (1): 57–66. doi:10.1023/B:CARD.0000025756.32499.6f.